Fasting-mimicking diet

Fasting-mimicking diet has been studied in 157 papers since 2015: 47 trials and 2 observational studies in people, 39 in animals, 1 in cells, 62 reviews; 30 in the past year. The newest paper, Nov 4, 2026: “From Fasting to Caloric Restriction: State of the Art and Clinical Implications”.

InterventionDietary restriction

157 papers study it307 findingsUpdated

3 new papers in 30 daysSee all 153 papers on fasting-mimicking diet

At a glance

A human trial reports lower biological age with a fasting-mimicking diet; independent labs report lower IGF-1 in humans and inflammation in mice. Human body-weight results include decreases and no clear effects. L-Nutra sponsors the registered aging trial, which is not completed, and 11 of 43 human papers declare ties to this developer.

307 findings in 96 papers from 2015 to 2026, 4 of them since June 2026

Independent labs found the same change in mice and people. 37 independent labs in 14 countries; 1 trial, 1 about aging.

“there was no difference in toxicity between both groups”
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trialNature communications2020doi:10.1038/s41467-020-16138-3

11 of its findings point the other way.

Mice and humans: replicated by independent labs. Cells: a single group. Worms or flies: nothing yet.
  • 37 independent labs in 14 countries
  • 11 findings against
  • 1 trial, 1 about aging
  • Funders: National Institute on Aging and others
  • 85 of 269 findings with company ties
  • 1 of 1 trial sponsored by its developers
  • Human trial46
  • Humans2
  • Animals36
  • Cells1
  • In silico3

36 studies gave fasting-mimicking diet to people and measured what changed.

What changedDesignPeopleSource

down: Decreases glucose4.7 mmol/L to 4.0 mmol/L

down: Decreases IGF-123 nmol/L to 17.9 nmol/L

up: Increases ketonenear zero to median 1.86 mmol/L

Trialtwo cycles of a 4-day FMD separated by 3 weeks of regular diet9 peopleHealthy volunteersNutrients, Aug 3, 2026

down: Decreases left ventricular massmean difference, -5.47 g

up: Improves early-to-late peak filling ratiomean difference, 0.27

up: Improves mitral annular early peak velocitymean difference, 0.84 cm/sec

Randomized trial6 months82 peopleBothmean age, 62.9 years ± 8.5Older adults; in individuals with type 2 diabetesRadiology. Cardiothoracic imaging, Jul 30, 2026

up: Improves clinical response69.2% FMD versus 43.8% control

up: Improves clinical remission64.6% FMD versus 37.5% control

down: Decreases calprotectin−22.0% versus 8.0%

Randomized trialthree months97 peoplemedian age 45.0 years (IQR 35.0 to 55.0)Patients with mild-to-moderate Crohn's diseaseNature medicine, Jan 13, 2026

down: Decreases body weight

down: Decreases fasting glucose

down: Decreases HOMA-IR

Randomized trial8 days30 people83.3% were femalemean age of 49.1 ± 11.8 yearsParticipants recruited from the San Antonio, Texas USA communityGeroScience, Dec 11, 2025

no change: Has no effect on quality of lifeunadjusted mean difference −0.04, 95% CI −0.10 to 0.03

Randomized trialone year92 peoplePatients with type 2 diabetesBMC primary care, Nov 10, 2025

What did studies of fasting-mimicking diet find?

193

Studies of fasting-mimicking diet measured 193 outcomes; the most studied are body weight (12 studies), IGF-1 (8) and inflammation (7).

Body weight

downin humans8downin mice2no changein humans1downin reviews1

12 studies
  1. Fasting-mimicking diet decreases body weight in humans.

    “Significant differences from baseline to the end of the dietary intervention at 6 days were observed between treatment groups, with an increase in β-hydroxybutyrate and decreases in weight, fasting glucose, insulin, and HOMA-IR in the FMD groups compared to the control group.”

    Human trial8 daysn = 30

    Effect of fasting-mimicking diet on markers of autophagy and metabolic health in human subjects

    GeroScience

  2. Fasting-mimicking diet decreases body weight in humans.

    “explore the effects of FMDs on the human salivary metabolic profiles and weight in a single-arm case study”

    Human trial

    Comprehensive Assessment of a Fasting-Mimicking Diet: Salivary Metabolite Profiles, Weight Loss, and Biomarker Analysis

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  3. Fasting-mimicking diet decreases body weight in humans (adjunct to usual care in type 2 diabetes) (-3.6 kg; 95% CI -5.2, -2.1).

    “and body weight (-3.6 kg; 95% CI -5.2, -2.1; p<0.001) at 12 months.”

    Human trialadjunct to usual care in type 2 diabetes5-day cycles monthly12 months

    Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial

    Diabetologia

  4. Fasting-mimicking diet decreases body weight in humans (−3.6 kg (95% CI −5.2, −2.1)).

    “There was a significant adjusted estimated treatment effect on body weight (−3.6 kg; 95% CI −5.2, −2.1; p<0.001), BMI (−1.2 kg/m2; 95% CI −1.7, −0.7; p<0.001), waist circumference (−3.5 cm; 95% CI −5.3, −1.6; p<0.001) and body fat percentage (−2.2%; 95% CI −3.3, −1.0; p<0.001) at 12 months”

    Human trial12 monthsn = 100

    Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial

    Diabetologia

  5. Fasting-mimicking diet decreases body weight in hypertensive patients with obesity/excess weight.

    “Both FMD and MD led to comparable decreases in weight, waist circumference, BMI, body fat mass and % body fat, total cholesterol, and leptin.”

    Human trialin hypertensive patients with obesity/excess weight4 months

    Fasting mimicking diet cycles versus a Mediterranean diet and cardiometabolic risk in overweight and obese hypertensive subjects: a randomized clinical trial

    npj metabolic health and disease

  6. Fasting-mimicking diet decreases body weight in humans (obesity hypoventilation syndrome) (considerably reduced).

    “Also, the mimic diet group's weight and neck circumference were considerably reduced after the intervention, with no change in the reflexology group.”

    Human trialobesity hypoventilation syndrometwo monthsmales

    Comparing the influence of foot reflexology and fasting mimicking diet on quality of life and sleep quality in obesity hypoventilation syndrome

    Journal of complementary & integrative medicine

  7. Fasting-mimicking diet decreases body weight in humans (prostate cancer with features of metabolic syndrome) (-3.79 kg (95% CI: -5.61, -1.97, p = 0.0002)).

    “On average patients' weights dropped by 3.79 kg (95% CI: -5.61, -1.97, p = 0.0002).”

    Human trialprostate cancer with features of metabolic syndromen = 29

    The impact of a fasting mimicking diet on the metabolic health of a prospective cohort of patients with prostate cancer: a pilot implementation study

    Prostate cancer and prostatic diseases

  8. Fasting-mimicking diet decreases body weight in humans.

    “The average weight loss in the FMD group after 5 days of the dietary intervention was 2.8 ± 0.2 kg of body weight.”

    Human trial5 days

    Fasting-Mimicking Diet Reduces Trimethylamine N-Oxide Levels and Improves Serum Biochemical Parameters in Healthy Volunteers

    Nutrients

  9. Fasting-mimicking diet decreases body weight in humans (-2.8 ± 0.2 kg).

    “Moreover, FMD led to a weight loss of 2.8 ± 0.2 kg and a subsequent reduction in BMI compared to baseline.”

    Human trial5-dayn = 24

    Fasting-Mimicking Diet Reduces Trimethylamine N-Oxide Levels and Improves Serum Biochemical Parameters in Healthy Volunteers

    Nutrients

  10. Fasting-mimicking diet showed no clear effect on body weight in humans (metabolically healthy women with obesity) (-2.29 (1.95) kg vs -1.13 (2.27) kg, p = 0.06).

    “There was no significant difference in weight loss between the two groups: mean weight change for CER was - 2.29 (standard deviation [SD], 1.95) kg compared to - 1.13 (2.27) kg for FMD (p = 0.06).”

    Human trialmetabolically healthy women with obesity2 monthsfemalesn = 60

    Effect of Fasting-Mimicking Diet or Continuous Energy Restriction on Weight Loss, Body Composition, and Appetite-Regulating Hormones Among Metabolically Healthy Women with Obesity: a Randomized Controlled, Parallel Trial

    Obesity surgery

All 14

IGF-1

downin humans8

8 studies
  1. Fasting-mimicking diet decreases IGF-1 in humans (23 nmol/L to 17.9 nmol/L).

    “Similarly, IGF-1 plasma levels decreased over time (p = 0.029) with the fed state 23 nmol/L (median, IQR 19.6–30.3) and FMD-fasted 17.9 nmol/L (median, IQR 12.4–27.6) showing the largest difference (p = 0.028; ).”

    Human trialn = 9

    Exploring the Immunomodulatory Effects of Fasting-Mimicking Diet in Healthy Individuals: A Pilot Study

    Nutrients

  2. Fasting-mimicking diet decreases IGF-1 in humans (healthy individuals).

    “FMD was associated with reduced plasma glucose and insulin-like growth factor-1”

    Human trialhealthy individualstwo cycles of a 4-day FMD separated by 3 weeks of regular dietn = 6

    Exploring the Immunomodulatory Effects of Fasting-Mimicking Diet in Healthy Individuals: A Pilot Study

    Nutrients

  3. Fasting-mimicking diet decreases IGF-1 in humans (at the end of the first and second FMD cycles; not significant at the third) (B = -23.29, p = 0.001 (first FMD); B = -16.20, p = 0.023 (second FMD)).

    “A decline in IGF-1 compared to baseline was observed to be statistically significant at the end of the first FMD”

    Human trialat the end of the first and second FMD cycles; not significant at the thirdrecipe-based34-54% of normal caloric intakethree FMD cycles

    The feasibility and safety of fasting-mimicking diet in breast cancer patients with chemotherapy in China

    Breast cancer research and treatment

  4. Fasting-mimicking diet decreases IGF-1 in humans.

    “Compared with T0, IGF-1 decreased significantly at T2 and T4, with p = 0.001 and p = 0.023 respectively.”

    Human trialthree cycles of the 5-day FMDfemalesn = 30

    The feasibility and safety of fasting-mimicking diet in breast cancer patients with chemotherapy in China

    Breast cancer research and treatment

  5. Fasting-mimicking diet decreases IGF-1 in humans during neoadjuvant chemotherapy (p = 0.006).

    “the median Insulin-like growth factor-1 (IGF1) (p = 0.006) and hs-CRP (p = 0.02) levels were significantly decreased in the FMD group”

    Human trialduring neoadjuvant chemotherapy

    Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study

    Frontiers in nutrition

  6. Fasting-mimicking diet decreases IGF-1 in humans (between baseline and after cycle 8).

    “On the other hand, the median levels of IGF-1 and hs-CRP was significantly decreased in FMD group between the two-time points (p = 0.006 and p = 0.02 respectively).”

    Human trialbetween baseline and after cycle 83 days before to and on the day of each cycle of chemotherapy

    Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study

    Frontiers in nutrition

  7. Fasting-mimicking diet decreases IGF-1 in humans (-37 ± 8 ng/mL).

    “We also observed a significant reduction in plasma insulin-like growth factor-1 (IGF-1) concentrations ( B) in the FMD group by 37 ± 8 ng/mL, which was not present in the VEG diet group.”

    Human trial5 days

    Fasting-Mimicking Diet Reduces Trimethylamine N-Oxide Levels and Improves Serum Biochemical Parameters in Healthy Volunteers

    Nutrients

  8. Fasting-mimicking diet decreases IGF-1 in cancer patients undergoing active treatment.

    “FMD reduced the serum c-peptide, IGF1, IGFBP3 and leptin levels”

    Human trialin cancer patients undergoing active treatment

    Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment

    Cancers

  9. Fasting-mimicking diet decreases IGF-1 in patients with hormone-receptor-positive breast cancer receiving estrogen therapy.

    “cycles of a fasting-mimicking diet cause metabolic changes analogous to those observed in mice, including reduced levels of insulin, leptin and IGF1”

    Human trialin patients with hormone-receptor-positive breast cancer receiving estrogen therapy

    Fasting-mimicking diet and hormone therapy induce breast cancer regression

    Nature

  10. Fasting-mimicking diet decreases IGF-1 in humans (-21.7 ± 46.2 ng/ml).

    “In conclusion, three cycles of the FMD reduced body weight, trunk and total body fat, blood pressure, and IGF-1 in comparison to a normal diet.”

    Human trial3 monthsn = 100

    Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease

    Science translational medicine

All 12

More on IGF-1

Inflammation

downin mice4downin reviews2downin humans1

7 studies
  1. Fasting-mimicking diet inhibits inflammation in humans.

    “The between-group analysis found that FMD->Control participants after six FMD cycles displayed a significant (p < 0.016) reduction in serum leptin levels, insulin, glucose, total cholesterol, LDL, CRP, AST and ALT, and HOMA-IR and an increase in ghrelin serum levels and HOMA %S with respect to Control->FMD subjects after 6 months on the control diet”

    Human trial6 monthly cycles5 consecutive days each month for 6 monthsn = 102

    Chemosensory and cardiometabolic improvements after a fasting-mimicking diet: A randomized cross-over clinical trial

    Cell reports. Medicine

  2. Fasting-mimicking diet decreases inflammation.

    “suppress inflammation”

    Review

    Effects of the periodic fasting-mimicking diet on health, lifespan, and multiple diseases: a narrative review and clinical implications

    Nutrition reviews

  3. Fasting-mimicking diet decreases inflammation in DSS-induced colitis.

    “FMD showed the most consistent beneficial impact.”

    Animalsin DSS-induced colitiscolonmales

    Restrictive diets have a beneficial impact on dextran sodium sulfate-induced colitis in male mice

    The Journal of nutrition

  4. Fasting-mimicking diet decreases inflammation in both cancer models treated with immune checkpoint inhibitors.

    “immune infiltration of CD3+ and CD8+ cells in myocardial tissues and systemic and myocardial markers of oxidative stress and inflammation are reduced.”

    Animalsin both cancer models treated with immune checkpoint inhibitorsmyocardial tissues

    Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects

    Nature communications

  5. Fasting-mimicking diet decreases inflammation in animal models of AD.

    “FMDs can reduce amyloid-beta accumulation, tau phosphorylation, and inflammation, as well as improve cognitive function in animal models of AD.”

    Reviewin animal models of AD

    The Potential of Fasting-Mimicking Diet as a Preventive and Curative Strategy for Alzheimer's Disease

    Biomolecules

  6. Fasting-mimicking diet inhibits inflammation in MPTP-induced PD mice.

    “FMD also inhibited neuro-inflammation”

    Animalsin MPTP-induced PD mice

    Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

  7. Fasting-mimicking diet decreases inflammation in chronic dextran sodium sulfate (DSS)-induced murine model.

    “These FMD cycles reduced intestinal inflammation, increased stem cell number, stimulated protective gut microbiota, and reversed intestinal pathology caused by DSS”

    Animalsin chronic dextran sodium sulfate (DSS)-induced murine modelintestine4-day cycles

    Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology

    Cell reports

More on Inflammation

HbA1c

downin humans4

4 studies
  1. Fasting-mimicking diet decreases HbA1c in humans (adjunct to usual care in type 2 diabetes) (-3.2 mmol/mol; 95% CI -6.2, -0.2).

    “improves HbA1c despite the reduction in medication use”

    Human trialadjunct to usual care in type 2 diabetes5-day cycles monthly12 months

    Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial

    Diabetologia

  2. Fasting-mimicking diet decreases HbA1c in humans (−3.2 mmol/mol (95% CI −8.0, −2.0)).

    “The HbA1c values decreased from 52.2 ± 9.3 mmol/mol (6.9 ± 0.8%) (mean ± SD) at baseline to 49.5 ± 8.2 mmol/mol (6.7 ± 0.8%) at 12 months in the FMD group, and increased from 53.7 ± 12.2 mmol/mol (7.1 ± 1.1%) to 53.8 ± 7.6 mmol/mol (7.1 ± 0.7%) in the control group, yielding adjusted estimated treatment effects of −3.2 mmol/mol (95% CI −8.0, −2.0) and −0.3% (95% CI −0.6, −0.0) (p=0.04; Table and Fig”

    Human trialblood12 monthsn = 100

    Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial

    Diabetologia

  3. Fasting-mimicking diet decreases HbA1c in humans (compared to baseline in hypertensive patients with obesity/excess weight) (p = 0.0059).

    “FMD decreased HbA1c (p = 0.0059) and IGF-1 (p = 0.0427)”

    Human trialcompared to baseline in hypertensive patients with obesity/excess weight4 months

    Fasting mimicking diet cycles versus a Mediterranean diet and cardiometabolic risk in overweight and obese hypertensive subjects: a randomized clinical trial

    npj metabolic health and disease

  4. Fasting-mimicking diet decreases HbA1c in humans (6.47 ± 0.51% vs 7.50 ± 0.50%).

    “The FPG was 5.25 ± 0.23 mmol/L in the experimental group and 6.27 ± 0.37 mmol/L in the control group, the 2hPG was 7.02 ± 2.27 mmol/L and 8.33 ± 0.89 mmol/L, respectively, and the HbA1c was 6.47 ± 0.51% and 7.50 ± 0.50%, respectively.”

    Human trial4-monthn = 100

    Effects of Fasting-Mimicking Diet and Specific Meal Replacement Foods on Blood Glucose Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial

    Oxidative medicine and cellular longevity

  5. Fasting-mimicking diet decreases HbA1c in humans (type 2 diabetes).

    “fasting blood glucose, 2-hour postprandial venous blood glucose, and glycosylated haemoglobin of the experimental group were all lower than those of the control group (P < 0.05)”

    Human trialtype 2 diabetes4 monthsn = 100

    Effects of Fasting-Mimicking Diet and Specific Meal Replacement Foods on Blood Glucose Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial

    Oxidative medicine and cellular longevity

  6. Fasting-mimicking diet decreases HbA1c in humans (meta-analysis of 11 RCTs) (WMD = -8.589 mmol/mol, 95% CI: -12.389, -4.769).

    “FMD significantly reduced glycated hemoglobin (HbA1c) (WMD = -8.589 mmol/mol, 95% CI: -12.389, -4.769)”

    Reviewmeta-analysis of 11 RCTs

    Impact of Fasting Mimicking Diet (FMD) on cardiovascular risk factors: a systematic review and meta-analysis of randomized control trials

    Diabetology & metabolic syndrome

More on HbA1c

Immune response

upin mice2upin humans1downin mice1

4 studies
  1. Fasting-mimicking diet activates immune response.

    “Together, these data indicate that the FMD, alone or in combination with standard antitumor therapies, downregulates immunosuppressive myeloid cell subsets, while at the same time increasing effector cells with an activated phenotype.”

    Human trialfive-day FMD followed by 16 to 23 days of refeedingn = 38

    Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer

    Cancer discovery

  2. Fasting-mimicking diet activates immune response in humans.

    “paralleled by enhanced intratumor Th1/cytotoxic responses”

    Human trialn = 101

    Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer

    Cancer discovery

  3. Fasting-mimicking diet activates immune response in mouse colorectal cancer model.

    “increased tumor-infiltration lymphocytes especially CD8+T cells”

    Animalsin mouse colorectal cancer model4-day

    Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression

    NPJ biofilms and microbiomes

  4. Fasting-mimicking diet activates immune response in mice.

    “FMD cycles enhance the efficacy of a range of drugs targeting different cancers in mice by stimulating antitumor immunity”

    Review

    Fasting and fasting mimicking diets in cancer prevention and therapy

    Trends in cancer

  5. Fasting-mimicking diet inhibits immune response in EAE mice.

    “the mice using FMD had significant decreases in EAE severity, immune cell infiltration in spinal cord and CNS demyelination.”

    Animalsin EAE micespinal cord

    Intermittent caloric restriction with a modified fasting-mimicking diet ameliorates autoimmunity and promotes recovery in a mouse model of multiple sclerosis

    The Journal of nutritional biochemistry

More on Immune response

Lifespan

upin mice2upin reviews2

4 studies
  1. Fasting-mimicking diet extends lifespan in animal studies.

    “In animal studies, FMD cycles promote stem cell activation, cellular reprogramming and autophagy leading to longevity extension”

    Reviewin animal studies

    Fasting Mimicking Diet Cycles, Regeneration, Biological Age, and Disease

    GSA 2025 abstract

  2. Fasting-mimicking diet extends lifespan.

    “FMD not only extends the lifespan and reduces the incidence of cancer and other diseases in healthy individuals”

    Review

    The Role of Fasting-Mimicking Diet in Cancer Therapy: Mechanisms, Challenges, and Clinical Prospects

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

  3. Fasting-mimicking diet extends lifespan in prematurely aging mice.

    “FMD significantly prolonged the lifespan of prematurely aging mice.”

    Animalsin prematurely aging mice

    Fasting mimicking diet extends lifespan and improves intestinal and cognitive health

    Food & function

  4. Fasting-mimicking diet extends lifespan in mice.

    “Bi-monthly FMD cycles started at middle age extended longevity, lowered visceral fat, reduced cancer incidence and skin lesions”

    Animalsbi-monthly

    A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan

    Cell metabolism

Biological age

downin humans3

3 studies
  1. Fasting-mimicking diet decreases biological age in humans (-2.5 years).

    “After 3 FMD cycles, median biological age in the 52 study participants decreased by nearly 2.5 years (Fig., p = 0.0007, Wilcoxon Rank Sum Scores ).”

    Human trialthree cycles of this 5-day FMDn = 52

    Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk

    Nature communications

  2. Fasting-mimicking diet decreases biological age in humans (independent of weight loss) (decrease of 2.5 years).

    “3 FMD cycles were associated with a decrease of 2.5 years in median biological age, independent of weight loss.”

    Human trialindependent of weight loss3 FMD cycles

    Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk

    Nature communications

  3. Fasting-mimicking diet decreases biological age in humans (-2.5 years (P = 0.003)).

    “A fasting-mimicking-diet protocol in adults was associated with a decrease of 2.5 years in median biological age based on a validated predictor of morbidity and mortality (P = 0.003)”

    Review

    Research Synthesis: Fasting Effects — full paper

    OSF Preprints (OSF Preprints)Preprint

  4. Fasting-mimicking diet decreases biological age in 2 different clinical trials (2.5 years).

    “supported by a 2.5 years of biological age reduction associated with 3 FMD cycles in 2 different clinical trials”

    Reviewin 2 different clinical trials3 FMD cycles

    Fasting Mimicking Diet Cycles, Regeneration, Biological Age, and Disease

    GSA 2025 abstract

More on Biological age

HOMA-IR

downin humans3

3 studies
  1. Fasting-mimicking diet decreases HOMA-IR in humans.

    “Significant differences from baseline to the end of the dietary intervention at 6 days were observed between treatment groups, with an increase in β-hydroxybutyrate and decreases in weight, fasting glucose, insulin, and HOMA-IR in the FMD groups compared to the control group.”

    Human trial8 daysn = 30

    Effect of fasting-mimicking diet on markers of autophagy and metabolic health in human subjects

    GeroScience

  2. Fasting-mimicking diet decreases HOMA-IR in humans (-3.8 (-5.6, -2.0); P ≤ 0.05).

    “FMD reduced HOMA-IR [-3.8 (-5.6, -2.0); P ≤ 0.05]”

    Human trialmonthly6 monthsn = 40

    Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study

    The Journal of clinical endocrinology and metabolism

  3. Fasting-mimicking diet decreases HOMA-IR in noninsulin treated participants (−3.8 (−5.6, −2.0), P ≤ 0.05).

    “For the exploratory outcomes, we found that HOMA-IR decreased after 6 diet cycles [−3.8 −5.6, −2.0); P ≤ 0.05] in the noninsulin treated participants of FMD group compared to M-Diet.”

    Human trialin noninsulin treated participants6 diet cycles

    Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study

    The Journal of clinical endocrinology and metabolism

  4. Fasting-mimicking diet decreases HOMA-IR in all patients (-3.8 (95% CI -5.6, -2.0; P≤0.05)).

    “FMD led to change in HOMA-IR of -3,8 (95% CI -5,6, -2.0; P≤0.05)”

    Human trialin all patientssix monthsn = 40

    A six-month periodic fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized controlled study

    medRxivPreprint

More on HOMA-IR

Cognitive function

upin mice2upin humans1upin reviews1

3 studies
  1. Fasting-mimicking diet improves cognitive function in mice.

    “FMD relieved anxiety and enhanced cognition in aged mice.”

    Animals

    Fasting mimicking diet extends lifespan and improves intestinal and cognitive health

    Food & function

  2. Fasting-mimicking diet improves cognitive function in humans.

    “Human studies have also reported improvements in AD biomarkers, cognitive functions, and subjective well-being measures following FMDs.”

    Review

    The Potential of Fasting-Mimicking Diet as a Preventive and Curative Strategy for Alzheimer's Disease

    Biomolecules

  3. Fasting-mimicking diet improves cognitive function in animal models of AD.

    “FMDs can reduce amyloid-beta accumulation, tau phosphorylation, and inflammation, as well as improve cognitive function in animal models of AD.”

    Reviewin animal models of AD

    The Potential of Fasting-Mimicking Diet as a Preventive and Curative Strategy for Alzheimer's Disease

    Biomolecules

  4. Fasting-mimicking diet improves cognitive function in mice.

    “In old mice, FMD cycles promoted hippocampal neurogenesis, lowered IGF-1 levels and PKA activity, elevated NeuroD1, and improved cognitive performance”

    Animals

    A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan

    Cell metabolism

Fat mass

downin humans3

3 studies
  1. Fasting-mimicking diet decreases fat mass in humans.

    “Concurrently, the FM and PBF decreased across all three cycle FMD (main time effect, p < 0.001, p = 0.001).”

    Human trialthree cycles of the 5-day FMDfemalesn = 30

    The feasibility and safety of fasting-mimicking diet in breast cancer patients with chemotherapy in China

    Breast cancer research and treatment

  2. Fasting-mimicking diet decreases fat mass in cancer patients undergoing active treatment.

    “while the fat mass decreased”

    Human trialin cancer patients undergoing active treatment

    Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment

    Cancers

  3. Fasting-mimicking diet decreases fat mass in humans (metabolically healthy women with obesity).

    “Favorable effects on fat mass and muscle mass were only seen in the FMD group.”

    Human trialmetabolically healthy women with obesity2 monthsfemalesn = 60

    Effect of Fasting-Mimicking Diet or Continuous Energy Restriction on Weight Loss, Body Composition, and Appetite-Regulating Hormones Among Metabolically Healthy Women with Obesity: a Randomized Controlled, Parallel Trial

    Obesity surgery

Body weight

downin humans2no changein humans1

3 studies
  1. Fasting-mimicking diet decreases body weight in humans (-3.79 kg (95% CI 1.97–5.61 kg)).

    “On average the weight of patients’ receiving 3 FMD cycles dropped by 3.79 kg after the 3 months, within which the true reduction is likely to be between 1.97 and 5.61 kg with 95% confidence.”

    Human trial3 cycles of a 4-day dietn = 29

    The impact of a fasting mimicking diet on the metabolic health of a prospective cohort of patients with prostate cancer: a pilot implementation study

    Prostate cancer and prostatic diseases

  2. Fasting-mimicking diet showed no clear effect on body weight in humans.

    “Handgrip strength and body weight did not change throughout the study ( C and ).”

    Human trial2 to 21 FMD cycles (average: 6.3 cycles per patient)n = 90

    Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment

    Cancers

  3. Fasting-mimicking diet decreases body weight in humans.

    “In conclusion, three cycles of the FMD reduced body weight, trunk and total body fat, blood pressure, and IGF-1 in comparison to a normal diet.”

    Human trial3 monthsn = 100

    Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease

    Science translational medicine

More on Body weight

Albumin-to-creatinine ratio

downin humans2no changein humans1

2 studies
  1. Fasting-mimicking diet showed no clear effect on albumin-to-creatinine ratio in humans (patients with macroalbuminuria at baseline) (434.0 (404.7, 463.4) mg/g; P = 0.23).

    “but not in those with macroalbuminuria [434.0 (404.7, 463.4) mg/g; P = 0.23]”

    Human trialpatients with macroalbuminuria at baselinemonthly6 monthsn = 40

    Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study

    The Journal of clinical endocrinology and metabolism

  2. Fasting-mimicking diet decreases albumin-to-creatinine ratio in humans (patients with microalbuminuria at baseline) (-30.3 (-35.7, -24.9) mg/g; P ≤ 0.05).

    “FMD led to a reduction of ACR in patients with microalbuminuria levels at baseline [-30.3 (-35.7, -24.9) mg/g; P ≤ 0.05]”

    Human trialpatients with microalbuminuria at baselinemonthly6 monthsn = 40

    Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study

    The Journal of clinical endocrinology and metabolism

  3. Fasting-mimicking diet decreases albumin-to-creatinine ratio in patients with microalbuminuria levels at baseline (−30.3 (−35.7, −24.9) mg/g, P ≤ 0.05).

    “In the prespecified subgroup analysis, when compared to the control group, FMD reduced ACR [−30.3 (−35.7, −24.9) mg/g; P ≤ 0.05] in patients with microalbuminuria levels at baseline”

    Human trialin patients with microalbuminuria levels at baseline6 diet cycles

    Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study

    The Journal of clinical endocrinology and metabolism

  4. Fasting-mimicking diet showed no clear effect on albumin-to-creatinine ratio in humans (110.3 (99.2, 121.5) mg/g, P = 0.45).

    “After 6 diet cycles, ACR did not change compared to respective baseline in both groups, and change in ACR was comparable between study groups [110.3 (99.2, 121.5) mg/g; P = 0.45].”

    Human trial6 diet cyclesn = 41

    Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study

    The Journal of clinical endocrinology and metabolism

  5. Fasting-mimicking diet decreases albumin-to-creatinine ratio in patients with microalbuminuria (-30.3 mg/g (95% CI -35.7, -24.9 mg/g; P≤0.05)).

    “-30.3mg/g (95% CI -35.7, -24.9mg/g; P≤0.05] in patients with microalbuminuria”

    Human trialin patients with microalbuminuriasix monthsn = 40

    A six-month periodic fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized controlled study

    medRxivPreprint

More on Albumin-to-creatinine ratio

Glucose

downin humans2−19%

2 studies
  1. Fasting-mimicking diet decreases glucose in humans (4.7 mmol/L to 4.0 mmol/L).

    “The plasma glucose level significantly decreased over time (p = 0.012) from the fed state 4.7 mmol/L (median, IQR 4.2–6.0) to FMD-fasted 4.0 mmol/L (median, IQR 3.63–4.35), with the most pronounced difference between overnight-fasted and FMD-fasted (p = 0.012; ).”

    Human trialn = 9

    Exploring the Immunomodulatory Effects of Fasting-Mimicking Diet in Healthy Individuals: A Pilot Study

    Nutrients

  2. Fasting-mimicking diet decreases glucose in humans (healthy individuals).

    “FMD was associated with reduced plasma glucose and insulin-like growth factor-1 and increased ketone levels.”

    Human trialhealthy individualstwo cycles of a 4-day FMD separated by 3 weeks of regular dietn = 6

    Exploring the Immunomodulatory Effects of Fasting-Mimicking Diet in Healthy Individuals: A Pilot Study

    Nutrients

  3. Fasting-mimicking diet decreases glucose (-18.6%).

    “In 99 evaluable patients the FMD reduced median plasma glucose concentration by 18.6% (range: −63.1%; +67.8%), serum insulin by 50.7% (range: −91.3%; +697%), and serum IGF1 by 30.3% (range: −72.3%; +139.8%), while it increased average urinary ketones from 0.18 mg/dL to 59.9 mg/dL.”

    Human trialfive-day FMD followed by 16 to 23 days of refeedingn = 99

    Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer

    Cancer discovery

  4. Fasting-mimicking diet decreases glucose in humans.

    “resulted in a consistent decrease of blood glucose and growth factor concentration”

    Human trialn = 101

    Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer

    Cancer discovery

More on Glucose

Quality of life

no changein humans1upin humans1

2 studies
  1. Fasting-mimicking diet showed no clear effect on quality of life in humans (unadjusted mean difference −0.04, 95% CI −0.10 to 0.03).

    “Though unadjusted differences in QALYs were not statistically significant, QALYs were lower in the FMD group compared to the control group.”

    Human trialone year

    Cost-effectiveness of a periodic fasting-mimicking diet programme in patients with type 2 diabetes: a trial-based analysis and a lifetime model-based analysis

    BMC primary care

  2. Fasting-mimicking diet showed no clear effect on quality of life in humans (type 2 diabetes) (-0.04, 95% CI -0.10 to + 0.03).

    “In the trial-based analysis (n = 92), QALYs were insignificantly lower (-0.04, 95% CI -0.10 to + 0.03)”

    Human trialtype 2 diabetesmonthly 5-consecutive dayone yearn = 92

    Cost-effectiveness of a periodic fasting-mimicking diet programme in patients with type 2 diabetes: a trial-based analysis and a lifetime model-based analysis

    BMC primary care

  3. Fasting-mimicking diet improves quality of life in humans (obesity hypoventilation syndrome) (p < 0.05).

    “The percentage change in the MOSAS questionnaire score and PSQI questionnaire was higher in the mimic diet group than in the reflexology group.”

    Human trialobesity hypoventilation syndrometwo monthsmales

    Comparing the influence of foot reflexology and fasting mimicking diet on quality of life and sleep quality in obesity hypoventilation syndrome

    Journal of complementary & integrative medicine

Muscle mass

no changein humans1upin humans1

2 studies
  1. Fasting-mimicking diet showed no clear effect on muscle mass in humans after three FMD cycles and a 21-day washout (-0.05 kg (95% CI -0.36 to 0.27)).

    “while muscle mass remained stable (- 0.05 kg, 95% CI - 0.36, 0.27 kg; p = 0.270)”

    Human trialafter three FMD cycles and a 21-day washoutrecipe-based34-54% of normal caloric intakethree FMD cyclesn = 27

    The feasibility and safety of fasting-mimicking diet in breast cancer patients with chemotherapy in China

    Breast cancer research and treatment

  2. Fasting-mimicking diet showed no clear effect on muscle mass in humans.

    “Notably, the FFM and SMM remained stable across all three cycles of FMD.”

    Human trialthree cycles of the 5-day FMDfemalesn = 30

    The feasibility and safety of fasting-mimicking diet in breast cancer patients with chemotherapy in China

    Breast cancer research and treatment

  3. Fasting-mimicking diet improves muscle mass in humans (metabolically healthy women with obesity).

    “Favorable effects on fat mass and muscle mass were only seen in the FMD group.”

    Human trialmetabolically healthy women with obesity2 monthsfemalesn = 60

    Effect of Fasting-Mimicking Diet or Continuous Energy Restriction on Weight Loss, Body Composition, and Appetite-Regulating Hormones Among Metabolically Healthy Women with Obesity: a Randomized Controlled, Parallel Trial

    Obesity surgery

All 193

What is fasting-mimicking diet linked with?

4

Studies link fasting-mimicking diet with 4 measures, most often cancer (3 studies).

Cancer

downin reviews2downin mice1

3 studies
  1. Fasting-mimicking diet lowers the risk of cancer.

    “reduces the incidence of cancer and other diseases in healthy individuals”

    Review

    The Role of Fasting-Mimicking Diet in Cancer Therapy: Mechanisms, Challenges, and Clinical Prospects

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

  2. Fasting-mimicking diet lowers the risk of cancer.

    “decrease the incidence of cancer and other age-related diseases”

    Review

    Fasting and fasting mimicking diets in cancer prevention and therapy

    Trends in cancer

  3. Fasting-mimicking diet lowers the risk of cancer in mice.

    “Bi-monthly FMD cycles started at middle age extended longevity, lowered visceral fat, reduced cancer incidence and skin lesions”

    Animalsbi-monthly

    A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan

    Cell metabolism

More on Cancer

Neutropenia

downin humans1

1 study
  1. Fasting-mimicking diet lowers the risk of neutropenia in humans during neo-adjuvant chemotherapy.

    “The occurrence of grade III vomiting and neutropenia in the control group was significantly higher than the FMD group (P = <0.001 and p = 0.04 respectively).”

    Human trialduring neo-adjuvant chemotherapy3 days before to and on the day of each cycle of chemotherapyn = 44

    Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study

    Frontiers in nutrition

More on Neutropenia

Immune response

upin humans1

1 study
  1. Fasting-mimicking diet is associated with immune response in humans (phase 1/2 clinical trials in patients with different tumor types).

    “results of phase 1/2 clinical trials showed that cyclic FMD is safe, feasible, and associated with positive metabolic and immunomodulatory effects in patients with different tumor types”

    Reviewphase 1/2 clinical trials in patients with different tumor types

    Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence

    Cell metabolism

More on Immune response

Severe adverse events

downin humans1

1 study
  1. Fasting-mimicking diet lowers the risk of severe adverse events (12.9% (90% CIs: 7.8–19.7%)).

    “The trial met its primary endpoint, with an incidence of severe grade 3 or 4 (G3/G4) FMD-related AEs of 12.9% (90% CIs: 7.8–19.7%), that is, significantly lower than the prespecified 20% threshold.”

    Human trialfive-day FMD followed by 16 to 23 days of refeedingn = 101

    Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer

    Cancer discovery

What acts on fasting-mimicking diet?

1

Studies name lactobacillus johnsonii as acting on fasting-mimicking diet.

Lactobacillus johnsonii

is required forin mice1

1 study
  1. Lactobacillus johnsonii is required for fasting-mimicking diet in CRC.

    “Lactobacillus. johnsonii is necessary for the anticancer process of FMD in CRC”

    Animalsin CRC

    Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression

    NPJ biofilms and microbiomes

More on Lactobacillus johnsonii

Has fasting-mimicking diet been tested in people?

1 of 1 about aging

Yes: 47 trials and 2 observational studies in people have been published.

About aging

Funding

1 grant since 2019

Japan Society for the Promotion of Science¥12M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Fasting-mimicking diets extend mouse lifespan across independent labs, and a mouse study reports improved cognition. Independent labs also report lower BMI and HbA1c in humans, while human trials report weight loss or no weight change. Some authors work at companies including L-Nutra, and some papers declare L-Nutra ties.

  2. Summary rewritten as its findings changed.

    As it read before

    A human trial in healthy people reports increased ketones and decreased IGF-1 and glucose with a fasting-mimicking diet, alongside increased HLA-DR+ T cells and TNF signaling in peripheral blood mononuclear cells. Reviews describe reduced insulin resistance and biological age in humans and lifespan extension in animals. Five findings come from one lab funded by Oncode Institute.

  3. Summary written from the findings.

Latest

Dec 2025: 6Jan 2026: 6Feb 2026: 2Mar 2026: 2Apr 2026: 0May 2026: 2Jun 2026: 3Jul 2026: 2Aug 2026: 1Sep 2026: 2Oct 2026: 2Nov 2026: 129 papers in 12 months

See all 153 papers on fasting-mimicking diet